1xbet 한국., Ltd.
Nutraceuticals
July 9, 2021
Pharmavite, a U.S. subsidiary of 1xbet 한국, acquires Uqora, a provider of women's urinary tract health products
Pharmavite, LLC, a California-based subsidiary of 1xbet 한국., Ltd. has acquired all shares of Uqora, Inc., a company focused on female urinary tract health through non-antibiotic products and platforms. These are complementary with Pharmavite's vitamins and supplements offerings and more broadly with Otsuka Pharmaceutical's emphasis on women's health. The acquisition of Uqora's shares occurred on July 1.
Uqora provides proactive urinary tract 1xbet 한국 products (supplements to actively maintain urinary tract 1xbet 한국) and reactive solutions for relief from urinary tract infections (UTIs). The company was founded in California (U.S.) in 2017 and has grown rapidly since its establishment.
UTIs are the most common bacterial 1xbet 한국fections requir1xbet 한국g medical treatment 1xbet 한국 the U.S. and are the second most common 1xbet 한국fection after the common cold.
UTIs disproportionately impact women - 60 percent will have at least one UTI 1xbet 한국 their life, with a 20 to 40 percent chance of UTI recurrence.*1
Current treatments rely heavily on antibiotics with a growing number of UTIs becoming resistant to antibiotics. Uqora helps people address UTIs 1xbet 한국 problems with a preventive approach that does not rely on drug treatments.
- 1Urology Care Foundation:https://www.urology1xbet 한국.org/urology-a-z/u/urinary-tract-infections-in-adults
Uqora's ma1xbet 한국 products
Makoto Inoue, president and representative director of 1xbet 한국, noted, "We have been supporting women's health through the provision of science-based products and information, such as Equelle® and Nature Made®, in the nutraceutical business by leveraging our expertise in pharmaceutical research and development. With the addition of Uqora to our group, we will be able to provide more complete support for women's health, including in the area of urinary tract infections, which affect many women. 1xbet 한국, Pharmavite, and Uqora aim to leverage synergies to achieve further growth in this field."
Jeff Boutelle, CEO of Pharmavite, enthused, "Uqora's scientific approach to women's urinary 1xbet 한국 is wholly consistent with our promise to provide consumers with high-quality, scientifically-based vitamins and supplements. Uqora also fits so well with our build-out of a comprehensive women's 1xbet 한국 platform inclusive of our existing Nature Made®and Equelle®brands."
Uqora CEO and co-founder Jenna Ryan commented, "Becoming part of the 1xbet 한국 family of companies is an invigorating development for me, for Uqora co-founder Spencer Gordon, and for the Uqora team. We expect to leverage the resources available from the health and wellness leaders at Pharmavite to accelerate our research and advance our capabilities to develop new products. Together with Pharmavite, I am confident that we can realize that vision."
Latest Nutraceutical Bus1xbet 한국ess related News Releases